JUBILANT PHARMOVA
|
JUBILANT PHARMOVA Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
Equity - Authorised | ₹143 Cr | ₹143 Cr | ₹143 Cr | ₹66 Cr | ₹66 Cr |
Equity - Issued | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
Equity Paid Up | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
Equity Shares Forfeited | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | ₹6.19 Cr | ₹3.66 Cr | ₹0.82 Cr | - | ₹0.05 Cr |
Total Reserves | ₹5,377 Cr | ₹5,299 Cr | ₹4,725 Cr | ₹5,588 Cr | ₹4,793 Cr |
Securities Premium | - | - | - | ₹587 Cr | ₹587 Cr |
Capital Reserves | ₹2.17 Cr | ₹6.13 Cr | ₹6.13 Cr | ₹219 Cr | ₹203 Cr |
Profit & Loss Account Balance | ₹4,537 Cr | ₹4,685 Cr | ₹4,318 Cr | ₹3,845 Cr | ₹3,103 Cr |
General Reserves | - | - | - | ₹737 Cr | ₹607 Cr |
Other Reserves | ₹838 Cr | ₹608 Cr | ₹401 Cr | ₹200 Cr | ₹293 Cr |
Reserve excluding Revaluation Reserve | ₹5,377 Cr | ₹5,299 Cr | ₹4,725 Cr | ₹5,588 Cr | ₹4,793 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹5,399 Cr | ₹5,319 Cr | ₹4,741 Cr | ₹5,604 Cr | ₹4,809 Cr |
Minority Interest | ₹-7.49 Cr | ₹-2.16 Cr | ₹0.03 Cr | - | ₹0.10 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹265 Cr | ₹201 Cr | ₹21 Cr | ₹729 Cr | ₹812 Cr |
Non Convertible Debentures | - | - | - | - | ₹644 Cr |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹307 Cr | ₹600 Cr | ₹21 Cr | ₹733 Cr | ₹245 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-41 Cr | ₹-399 Cr | - | ₹-4.11 Cr | ₹-77 Cr |
Unsecured Loans | ₹2,845 Cr | ₹2,263 Cr | ₹2,543 Cr | ₹3,011 Cr | ₹3,431 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | ₹2,845 Cr | ₹756 Cr | ₹1,094 Cr | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | ₹1,507 Cr | ₹1,449 Cr | ₹3,011 Cr | ₹3,431 Cr |
Deferred Tax Assets / Liabilities | ₹79 Cr | ₹142 Cr | ₹93 Cr | ₹52 Cr | ₹53 Cr |
Deferred Tax Assets | ₹538 Cr | ₹425 Cr | ₹501 Cr | ₹796 Cr | ₹729 Cr |
Deferred Tax Liability | ₹616 Cr | ₹566 Cr | ₹594 Cr | ₹848 Cr | ₹781 Cr |
Other Long Term Liabilities | ₹484 Cr | ₹220 Cr | ₹222 Cr | ₹145 Cr | ₹10 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹92 Cr | ₹96 Cr | ₹94 Cr | ₹151 Cr | ₹114 Cr |
Total Non-Current Liabilities | ₹3,765 Cr | ₹2,922 Cr | ₹2,973 Cr | ₹4,088 Cr | ₹4,420 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹821 Cr | ₹568 Cr | ₹520 Cr | ₹1,090 Cr | ₹1,020 Cr |
Sundry Creditors | ₹821 Cr | ₹568 Cr | ₹520 Cr | ₹1,090 Cr | ₹1,020 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹552 Cr | ₹839 Cr | ₹372 Cr | ₹674 Cr | ₹474 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹71 Cr | ₹90 Cr | - | - | - |
Interest Accrued But Not Due | ₹5.66 Cr | ₹13 Cr | ₹11 Cr | ₹44 Cr | ₹65 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | ₹9.37 Cr |
Other Liabilities | ₹475 Cr | ₹735 Cr | ₹360 Cr | ₹630 Cr | ₹399 Cr |
Short Term Borrowings | ₹258 Cr | ₹64 Cr | ₹20 Cr | ₹650 Cr | ₹500 Cr |
Secured ST Loans repayable on Demands | ₹258 Cr | ₹64 Cr | ₹20 Cr | ₹270 Cr | ₹236 Cr |
Working Capital Loans- Sec | ₹258 Cr | ₹64 Cr | ₹20 Cr | ₹270 Cr | ₹236 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-258 Cr | ₹-64 Cr | ₹-20 Cr | ₹110 Cr | ₹28 Cr |
Short Term Provisions | ₹141 Cr | ₹121 Cr | ₹137 Cr | ₹205 Cr | ₹96 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹62 Cr | ₹35 Cr | ₹47 Cr | ₹106 Cr | ₹28 Cr |
Provision for post retirement benefits | - | - | ₹59 Cr | ₹64 Cr | ₹47 Cr |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹78 Cr | ₹87 Cr | ₹30 Cr | ₹35 Cr | ₹21 Cr |
Total Current Liabilities | ₹1,772 Cr | ₹1,592 Cr | ₹1,049 Cr | ₹2,619 Cr | ₹2,090 Cr |
Total Liabilities | ₹10,929 Cr | ₹9,830 Cr | ₹8,763 Cr | ₹12,310 Cr | ₹11,319 Cr |
ASSETS | |||||
Gross Block | ₹7,432 Cr | ₹6,759 Cr | ₹6,090 Cr | ₹7,983 Cr | ₹6,905 Cr |
Less: Accumulated Depreciation | ₹2,249 Cr | ₹1,888 Cr | ₹1,481 Cr | ₹1,643 Cr | ₹1,257 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹5,183 Cr | ₹4,871 Cr | ₹4,609 Cr | ₹6,340 Cr | ₹5,648 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹773 Cr | ₹292 Cr | ₹278 Cr | ₹264 Cr | ₹492 Cr |
Non Current Investments | ₹256 Cr | ₹239 Cr | ₹241 Cr | ₹69 Cr | ₹115 Cr |
Long Term Investment | ₹256 Cr | ₹239 Cr | ₹241 Cr | ₹69 Cr | ₹115 Cr |
Quoted | - | - | - | ₹0.43 Cr | ₹2.76 Cr |
Unquoted | ₹256 Cr | ₹239 Cr | ₹241 Cr | ₹69 Cr | ₹112 Cr |
Long Term Loans & Advances | ₹162 Cr | ₹118 Cr | ₹63 Cr | ₹87 Cr | ₹69 Cr |
Other Non Current Assets | ₹4.09 Cr | ₹3.98 Cr | ₹1.35 Cr | ₹7.53 Cr | ₹0.66 Cr |
Total Non-Current Assets | ₹7,167 Cr | ₹6,320 Cr | ₹5,811 Cr | ₹7,272 Cr | ₹6,734 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹1,381 Cr | ₹1,255 Cr | ₹1,129 Cr | ₹1,845 Cr | ₹1,417 Cr |
Raw Materials | ₹433 Cr | ₹364 Cr | ₹347 Cr | ₹578 Cr | ₹474 Cr |
Work-in Progress | ₹453 Cr | ₹379 Cr | ₹347 Cr | ₹464 Cr | ₹335 Cr |
Finished Goods | ₹242 Cr | ₹252 Cr | ₹243 Cr | ₹472 Cr | ₹338 Cr |
Packing Materials | - | - | - | - | - |
Stores Ā and Spare | ₹177 Cr | ₹156 Cr | ₹134 Cr | ₹131 Cr | ₹112 Cr |
Other Inventory | ₹76 Cr | ₹103 Cr | ₹58 Cr | ₹201 Cr | ₹158 Cr |
Sundry Debtors | ₹961 Cr | ₹928 Cr | ₹820 Cr | ₹1,293 Cr | ₹1,272 Cr |
Debtors more than Six months | ₹112 Cr | ₹46 Cr | ₹26 Cr | - | - |
Debtors Others | ₹900 Cr | ₹908 Cr | ₹816 Cr | ₹1,316 Cr | ₹1,289 Cr |
Cash and Bank | ₹1,014 Cr | ₹984 Cr | ₹671 Cr | ₹1,400 Cr | ₹1,370 Cr |
Cash in hand | ₹0.03 Cr | ₹0.04 Cr | ₹0.07 Cr | ₹0.18 Cr | ₹0.16 Cr |
Balances at Bank | ₹1,011 Cr | ₹979 Cr | ₹662 Cr | ₹1,384 Cr | ₹1,365 Cr |
Other cash and bank balances | ₹3.21 Cr | ₹5.06 Cr | ₹9.11 Cr | ₹16 Cr | ₹5.20 Cr |
Other Current Assets | ₹135 Cr | ₹111 Cr | ₹242 Cr | ₹420 Cr | ₹486 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹0.67 Cr | ₹1.10 Cr | ₹1.12 Cr | ₹1.43 Cr | ₹2.12 Cr |
Prepaid Expenses | ₹90 Cr | ₹83 Cr | ₹82 Cr | ₹74 Cr | ₹69 Cr |
Other current_assets | ₹44 Cr | ₹26 Cr | ₹159 Cr | ₹344 Cr | ₹415 Cr |
Short Term Loans and Advances | ₹271 Cr | ₹231 Cr | ₹90 Cr | ₹80 Cr | ₹40 Cr |
Advances recoverable in cash or in kind | ₹137 Cr | ₹99 Cr | ₹64 Cr | ₹77 Cr | ₹35 Cr |
Advance income tax and TDS | ₹12 Cr | ₹0.18 Cr | ₹24 Cr | ₹0.34 Cr | ₹1.17 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹122 Cr | ₹132 Cr | ₹1.43 Cr | ₹3.45 Cr | ₹3.68 Cr |
Total Current Assets | ₹3,762 Cr | ₹3,509 Cr | ₹2,953 Cr | ₹5,038 Cr | ₹4,585 Cr |
Net Current Assets (Including Current Investments) | ₹1,990 Cr | ₹1,918 Cr | ₹1,904 Cr | ₹2,419 Cr | ₹2,495 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹10,929 Cr | ₹9,830 Cr | ₹8,763 Cr | ₹12,310 Cr | ₹11,319 Cr |
Contingent Liabilities | ₹421 Cr | ₹420 Cr | ₹422 Cr | ₹702 Cr | ₹595 Cr |
Total Debt | ₹3,410 Cr | ₹2,928 Cr | ₹2,584 Cr | ₹4,628 Cr | ₹4,840 Cr |
Book Value | 339.04 | 333.91 | 297.84 | 351.83 | 301.93 |
Adjusted Book Value | 339.04 | 333.91 | 297.84 | 351.83 | 301.93 |
Compare Balance Sheet of peers of JUBILANT PHARMOVA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JUBILANT PHARMOVA | ₹10,779.0 Cr | 1.7% | 18.7% | 122.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,831.0 Cr | -0.1% | -2.8% | 50.3% | Stock Analytics | |
CIPLA | ₹113,471.0 Cr | 4.5% | -3.1% | 52.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,713.0 Cr | 4.6% | 1.4% | 22.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹101,960.0 Cr | 4.7% | 10.8% | 18.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,687.8 Cr | 3.1% | -4.1% | 80.4% | Stock Analytics |
JUBILANT PHARMOVA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JUBILANT PHARMOVA | 1.7% |
18.7% |
122.1% |
SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses